Literature DB >> 27837593

The microRNA-200 family: still much to discover.

Daniel Senfter, Sibylle Madlener, Georg Krupitza, Robert M Mader.   

Abstract

In the last decade, microRNAs (miRs or miRNAs) became of great interest in cancer research due to their multifunctional and active regulation in a variety of vital cellular processes. In this review, we discuss the miR-200 family, which is composed of five members (miR-141, miR-200a/200b/200c and miR-429). Although being among the best investigated miRNAs in the field, there are still many open issues. Here, we describe the potential role of miR-200 as prognostic and/or predictive biomarker, its influence on motility and cell migration as well as its role in epithelial to mesenchymal transition (EMT) and metastasis formation in different tumour types. Recent studies also demonstrated the influence of miR-200 on drug resistance and described a correlation between miR-200 expression levels and overall survival of patients. Despite intense research in this field, the full role of the miR-200 family in cancer progression and metastasis is not completely understood and seems to differ between different tumour types and different cellular backgrounds. To elucidate these differences further, a finer characterisation of the role of the individual miRNA-200 family members is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27837593     DOI: 10.1515/bmc-2016-0020

Source DB:  PubMed          Journal:  Biomol Concepts        ISSN: 1868-5021


  29 in total

1.  Down-regulation of microRNA-200b is a potential prognostic marker of lung cancer in southern-central Chinese population.

Authors:  Wen Li; Ming Xi Jia; Jing Deng; Jian Hui Wang; Qin Lu Lin; Jian Xin Tang; Xiao Xi Zeng; Fang Cai; Liang Ma; Wei Su; Xue Ying Liu; Cun Liu; Sha Sha Wang; Li Yi Zhou
Journal:  Saudi J Biol Sci       Date:  2018-08-31       Impact factor: 4.219

2.  Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.

Authors:  Melanie Tran; Sang-Min Lee; Dong-Ju Shin; Li Wang
Journal:  JCI Insight       Date:  2017-11-02

3.  EMT in salivary gland tumors: the expression of microRNAs miR-155 and miR-200c is associated with clinical-pathological parameters.

Authors:  Leandra Ernst Kerche; Elen Alves de Sousa; Cristiane Helena Squarize; Katia Klug Oliveira; Fabio Albuquerque Marchi; Bárbara Beltrame Bettim; Luiz Paulo Kowalski; Fernando Augusto Soares; Silvia Vanessa Lourenço; Cláudia Malheiros Coutinho-Camillo
Journal:  Mol Biol Rep       Date:  2022-01-04       Impact factor: 2.316

4.  Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy.

Authors:  Minggang Zhang; Zeguo Zhao; Yuri Pritykin; Margaret Hannum; Andrew C Scott; Fengshen Kuo; Viraj Sanghvi; Timothy A Chan; Venkatraman Seshan; Hans-Guido Wendel; Andrea Schietinger; Michel Sadelain; Morgan Huse
Journal:  Sci Transl Med       Date:  2021-09-15       Impact factor: 19.319

5.  Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice.

Authors:  Anna Kovalchuk; Yaroslav Ilnytskyy; Rocio Rodriguez-Juarez; Amanda Katz; David Sidransky; Bryan Kolb; Olga Kovalchuk
Journal:  Oncotarget       Date:  2017-08-03

6.  Akt Protein Kinase, miR-200/miR-182 Expression and Epithelial-Mesenchymal Transition Proteins in Hibernating Ground Squirrels.

Authors:  Yang-Ja Lee; Joshua D Bernstock; Dace Klimanis; John M Hallenbeck
Journal:  Front Mol Neurosci       Date:  2018-01-30       Impact factor: 5.639

Review 7.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

Review 8.  The roles of microRNA families in hepatic fibrosis.

Authors:  Xue-Ping Jiang; Wen-Bing Ai; Lin-Yan Wan; Yan-Qiong Zhang; Jiang-Feng Wu
Journal:  Cell Biosci       Date:  2017-07-04       Impact factor: 7.133

9.  Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.

Authors:  Li Tang; Da Wei; Xinyu Xu; Xuelian Mao; Dongping Mo; Linping Yan; Weiguo Xu; Feng Yan
Journal:  NPJ Breast Cancer       Date:  2021-07-16

10.  MicroRNA-200a/200b Modulate High Glucose-Induced Endothelial Inflammation by Targeting O-linked N-Acetylglucosamine Transferase Expression.

Authors:  Wan-Yu Lo; Wen-Kai Yang; Ching-Tien Peng; Wan-Yu Pai; Huang-Joe Wang
Journal:  Front Physiol       Date:  2018-04-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.